Literature DB >> 20236022

Inflammation stimulates thrombopoietin (Tpo) expression in rat brain-derived microvascular endothelial cells, but suppresses Tpo in astrocytes and microglia.

Juan Zhang1, Dorette Freyer, Olga Rung, Ae-Rie Im, Olaf Hoffmann, Christof Dame.   

Abstract

Thrombopoietin (Tpo) and its receptor (c-Mpl; TpoR), which primary regulate megakaryopoiesis and platelet production, are also expressed in the central nervous system (CNS). Increased Tpo concentrations are present in the cerebrospinal fluid (CSF) of some patients with bacterial or viral meningitis. Since previous data implicated a proapoptotic role of Tpo on newly generated neuronal cells, we herein elucidated the regulation of Tpo in primary rat neurons (e17), astrocytes, and microglia (p0-p3), as well as in brain-derived vascular endothelial cells of 3-week-old rats after exposure to bacterial lipopolysaccharide (LPS). LPS inhibited Tpo gene expression in astrocytes and microglia, but not in neurons, most likely due to absence of Toll-like receptor 4 in neurons. While Tpo mRNA expression recovered in astrocytes after 24 h, it remained suppressed in microglia. Furthermore, we detected Tpo mRNA expression in primary brain-derived vascular endothelial cells, which also express the TpoR. In these cells, LPS significantly up-regulated Tpo mRNA expression. TpoR mRNA and protein expression remained constitutive in all cell types. Thus, our data provide evidence for a cell-type-specific modulation of Tpo mRNA expression by inflammation in brain-derived cells. Transient down-regulation of Tpo expression in astrocytes and microglia may limit Tpo-induced neuronal cell death in inflammatory brain disorders.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20236022     DOI: 10.1089/jir.2009.0062

Source DB:  PubMed          Journal:  J Interferon Cytokine Res        ISSN: 1079-9907            Impact factor:   2.607


  7 in total

1.  G-CSF-mediated thrombopoietin release triggers neutrophil motility and mobilization from bone marrow via induction of Cxcr2 ligands.

Authors:  Anja Köhler; Katia De Filippo; Mike Hasenberg; Cindy van den Brandt; Emma Nye; Martin P Hosking; Thomas E Lane; Linda Männ; Richard M Ransohoff; Anja E Hauser; Oliver Winter; Burkhart Schraven; Hartmut Geiger; Nancy Hogg; Matthias Gunzer
Journal:  Blood       Date:  2011-01-11       Impact factor: 22.113

Review 2.  The biology of thrombopoietin and thrombopoietin receptor agonists.

Authors:  David J Kuter
Journal:  Int J Hematol       Date:  2013-07-03       Impact factor: 2.490

3.  Thrombopoietin contributes to neuronal damage in experimental bacterial meningitis.

Authors:  Olaf Hoffmann; Olga Rung; Ae-Rie Im; Dorette Freyer; Juan Zhang; Josephin Held; Werner Stenzel; Christof Dame
Journal:  Infect Immun       Date:  2010-12-13       Impact factor: 3.441

4.  Lung Endothelial MicroRNA-1 Regulates Tumor Growth and Angiogenesis.

Authors:  Asawari Korde; Lei Jin; Jian-Ge Zhang; Anuradha Ramaswamy; Buqu Hu; Saeed Kolahian; Brenda Juan Guardela; Jose Herazo-Maya; Jill M Siegfried; Laura Stabile; Margaret A Pisani; Roy S Herbst; Naftali Kaminski; Jack A Elias; Jonathan T Puchalski; Shervin S Takyar
Journal:  Am J Respir Crit Care Med       Date:  2017-12-01       Impact factor: 21.405

5.  Expression pattern of the thrombopoietin receptor (Mpl) in the murine central nervous system.

Authors:  Anna Ivanova; Jens Wuerfel; Juan Zhang; Olaf Hoffmann; Matthias Ballmaier; Christof Dame
Journal:  BMC Dev Biol       Date:  2010-07-28       Impact factor: 1.978

6.  Protected graft copolymer-formulated fibroblast growth factors mitigate the lethality of partial body irradiation injury.

Authors:  Gerardo M Castillo; Akiko Nishimoto-Ashfield; Cynthia C Jones; Kasim K Kabirov; Alexander Zakharov; Alexander V Lyubimov
Journal:  PLoS One       Date:  2017-02-16       Impact factor: 3.240

Review 7.  Thrombopoietin as biomarker and mediator of cardiovascular damage in critical diseases.

Authors:  Enrico Lupia; Alberto Goffi; Ornella Bosco; Giuseppe Montrucchio
Journal:  Mediators Inflamm       Date:  2012-04-05       Impact factor: 4.711

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.